Tristel plc (AIM:TSTL)
London · Delayed Price · Currency is GBP · Price in GBX 355.00
-13.00 (-3.53%)
At close: Dec 5, 2025
Tristel Market Cap
Tristel has a market cap or net worth of 169.5 million as of December 5, 2025. Its market cap has decreased by -19.23% in one year.
Market Cap
169.50M
Enterprise Value
162.54M
Revenue
46.46M
Ranking
n/a
PE Ratio
25.67
Stock Price
355.00
Market Cap Chart
Since June 1, 2005, Tristel's market cap has increased from 6.91M to 169.50M, an increase of 2,354.06%. That is a compound annual growth rate of 16.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 175.71M | -13.31% |
| Dec 31, 2024 | 202.69M | -7.08% |
| Dec 29, 2023 | 218.13M | 18.41% |
| Dec 30, 2022 | 184.21M | -14.20% |
| Dec 31, 2021 | 214.69M | -12.43% |
| Dec 31, 2020 | 245.16M | 42.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.77B |
| GSK plc | 73.29B |
| Haleon | 32.02B |
| Smith & Nephew | 10.44B |
| Convatec Group | 4.49B |
| Hikma Pharmaceuticals | 3.52B |
| HUTCHMED (China) | 1.84B |
| Genus | 1.77B |